FMS icon

Fresenius Medical Care

Positive
Neutral
Negative
Sentiment 3-Months
Positive
Neutral 21.4%
Negative

Positive
Zacks Investment Research
5 days ago
Why Fresenius (FMS) is a Top Value Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Why Fresenius (FMS) is a Top Value Stock for the Long-Term
Negative
Zacks Investment Research
20 days ago
Reasons to Retain Fresenius Medical Stock in Your Portfolio for Now
FMS eyes growth on value-based care surge and FME25+ savings, but regulatory headwinds, flat volumes and China weakness cloud outlook.
Reasons to Retain Fresenius Medical Stock in Your Portfolio for Now
Positive
Zacks Investment Research
21 days ago
Fresenius (FMS) is a Top-Ranked Value Stock: Should You Buy?
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Fresenius (FMS) is a Top-Ranked Value Stock: Should You Buy?
Positive
Zacks Investment Research
1 month ago
Here's Why Fresenius (FMS) is a Strong Value Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Here's Why Fresenius (FMS) is a Strong Value Stock
Positive
Zacks Investment Research
1 month ago
FMS Stock Rises as Q4 Earnings & Sales Beat Estimates, Margins Expand
FMS tops Q4 estimates as EPS jumps 59% and margins expand, powered by savings from its FME25+ program despite portfolio-optimization-driven sales pressure.
FMS Stock Rises as Q4 Earnings & Sales Beat Estimates, Margins Expand
Neutral
Seeking Alpha
1 month ago
Fresenius Medical Care AG (FMS) Q4 2025 Earnings Call Transcript
Fresenius Medical Care AG (FMS) Q4 2025 Earnings Call Transcript
Fresenius Medical Care AG (FMS) Q4 2025 Earnings Call Transcript
Neutral
PRNewsWire
1 month ago
Fresenius Medical Care delivers 27% earnings growth in 2025 and reaches upper end of its financial outlook; margin within 2025 mid-term target band
Strong organic revenue growth1 in 2025 of 8% driven by all operating segments Driven by an exceptional Q4, full year operating income2 growth of 27% reached top end of financial outlook, resulting in a significant margin step up to 11.3% Reported operating income grew by 31%, reported net income3 by 82% Earnings per share2 (EPS) grew by 44%, supported by the accelerated share buyback program Dividend of EUR 1.49 (+3%) planned to be proposed FY 2026 outlook operating income is forecast to remain on a consistent level despite significant additional headwinds BAD HOMBURG, Germany, Feb. 24, 2026 /PRNewswire/ -- "Fresenius Medical Care closed a milestone year marked by outstanding profitability gains. Over the past three years, we built a stronger and more resilient company, meeting all key financial and strategic aspects of the mid-term outlook that we had set for 2025.
Fresenius Medical Care delivers 27% earnings growth in 2025 and reaches upper end of its financial outlook; margin within 2025 mid-term target band
Negative
WSJ
1 month ago
Fresenius Medical Care Shares Drop After Outlook, U.S. Performance Underwhelms
Shares in the dialysis specialist were down 7.1% in European midday trade, with the decline erasing gains since the start of 2026.
Fresenius Medical Care Shares Drop After Outlook, U.S. Performance Underwhelms
Positive
Reuters
1 month ago
Fresenius Medical Care's operating profit surges in Q4
Fresenius Medical Care reported a sharp rise in fourth‑quarter operating income on Tuesday, helped by accelerating cost savings and favourable reimbursement effects.
Fresenius Medical Care's operating profit surges in Q4
Positive
Zacks Investment Research
2 months ago
Here's Why Fresenius (FMS) is a Strong Value Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Here's Why Fresenius (FMS) is a Strong Value Stock